Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Chirurgia (Bucur) ; 117(3): 317-327, 2022 Jun.
Article in English | MEDLINE | ID: mdl-36049090

ABSTRACT

Introduction: Abstract COVID-19 (Coronavirus-19 disease), a new clinical entity caused by SARS-COV-2 infection, could explain the physiopathology of cervicothoracic air collections (pneumothorax, pneumomediastinum, and subcutaneous emphysema). Material and Methods: We conducted an 8-months retrospective analysis of a single-center SARS-CoV-2 cases associating pneumothorax, pneumomediastinum, and subcutaneous emphysema, either alone or combined. Results: All non-intubated patients with the complications cited above had a favorable outcome after pleural drainage, percutaneous drainage, and/or conservative treatment, while the intubated patients, with multiple comorbidities, have had an unfavorable outcome, regardless the chosen treatment. Pleural drainage was used for pneumothorax cases; pneumomediastinum with subcutaneous emphysema required insertion of subcutaneous needles or angio-catheters with manual decompressive massage. Conservative methods of treatment were used for patients with pneumomediastinum and medium or severe respiratory disfunction. Conclusions: Etiopathogenic classification of pneumothorax should include SARS-CoV-2 infection as a possible cause of secondary spontaneous pneumothorax due to COVID-19 pneumonia. Survival rate after the occurrence of these complications was small (18,75%), 4 of the patients were cured, 2 had a favorable outcome and 26 have died. Pleural drainage which is mandatory to do for patients with pneumothorax complication in COVID -19 pneumonia, doesn't change the prognosis for those with severe affecting lungs, because the prolonged ventilation and the other comorbidities have led to death in most of these cases.


Subject(s)
COVID-19 , Mediastinal Emphysema , Pneumothorax , Subcutaneous Emphysema , COVID-19/complications , COVID-19/therapy , Humans , Mediastinal Emphysema/epidemiology , Mediastinal Emphysema/etiology , Mediastinal Emphysema/therapy , Pneumothorax/epidemiology , Pneumothorax/etiology , Pneumothorax/therapy , Retrospective Studies , SARS-CoV-2 , Subcutaneous Emphysema/complications , Subcutaneous Emphysema/therapy , Treatment Outcome
2.
Medicina (Kaunas) ; 58(6)2022 May 27.
Article in English | MEDLINE | ID: mdl-35743981

ABSTRACT

Background and Objectives: Malignant neoplasms are common causes of acute pleuropericardial effusion. Pleuropericarditis denotes poor patient prognosis, is associated with shortened average survival time, and represents a surgical emergency. Materials and Methods: We analyzed the impact of two minimally invasive surgical approaches, the type of cancer, and other clinical variables on the mortality of 338 patients with pleuropericarditis admitted to an emergency hospital in Romania between 2009 and 2020. All patients underwent minimally invasive surgeries to prevent the recurrence of the disease and to increase their life expectancy. Log-rank tests were used to check for survival probability differences by surgical approach. We also applied univariate and multivariate Cox proportional hazard models to assess the effect of each covariate. Results: No significant differences were found in the 2-year overall survival rate between patients who underwent the two types of surgery. The multivariate Cox proportional regression model adjusted for relevant covariates showed that age, having lung cancer, and a diagnosis of pericarditis and right pleural effusion increased the mortality risk. The surgical approach was not associated with mortality in these patients. Conclusion: These findings open up avenues for future research to advance the understanding of survival among patients with pleuropericarditis.


Subject(s)
Lung Neoplasms , Pericarditis , Pleural Effusion , Humans , Lung Neoplasms/pathology , Minimally Invasive Surgical Procedures , Pericarditis/etiology , Pericarditis/surgery , Pleural Effusion/etiology , Retrospective Studies
3.
J Enzyme Inhib Med Chem ; 30(2): 283-5, 2015 Apr.
Article in English | MEDLINE | ID: mdl-24964343

ABSTRACT

Stochastic sensing was employed for pattern recognition of HER-1 in biological fluids. Nanostructured materials such as 5,10,15,20-tetraphenyl-21H,23H-porphyrin, maltodextrin and α-cyclodextrin were used to modify diamond paste for stochastic sensing of HER-1. Pattern recognition of HER-1 in biological fluids was performed in a linear concentration range between 5.60 × 10(-11) and 9.72 × 10(-7 )mg ml(-1). The lower limits of determination (10(-12 )mg ml(-1) magnitude order) were recorded when maltodextrin and α-cyclodextrin were used for stochastic sensing. The pattern recognition test of HER-1 in biological fluids samples shows high reliability for both qualitative and quantitative assay.


Subject(s)
Ascitic Fluid/chemistry , Biomarkers, Tumor/isolation & purification , Biosensing Techniques/methods , ErbB Receptors/isolation & purification , Nanostructures/chemistry , Pattern Recognition, Automated/methods , Biomarkers, Tumor/blood , ErbB Receptors/blood , Humans , Polysaccharides/chemistry , Porphyrins/chemistry , Stochastic Processes , alpha-Cyclodextrins/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...